HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Qiuju Sheng Selected Research

D-LL-37

1/2016Enhanced LL-37 expression following vitamin D supplementation in patients with cirrhosis and spontaneous bacterial peritonitis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Qiuju Sheng Research Topics

Disease

4Infections
01/2022 - 01/2013
3Hepatocellular Carcinoma (Hepatoma)
01/2022 - 10/2018
2Fibrosis (Cirrhosis)
01/2022 - 01/2016
2Hepatitis B
10/2020 - 01/2013
2Chronic Hepatitis B
01/2020 - 01/2020
2Liver Diseases (Liver Disease)
10/2018 - 01/2016
2Hepatitis
01/2018 - 03/2015
1Coinfection
01/2022
1Carcinogenesis
01/2021
1Neoplasm Metastasis (Metastasis)
01/2021
1Chemical and Drug Induced Liver Injury
11/2020
1Hepatitis E
01/2020
1Viremia
01/2018
1Ascites
01/2016
1Peritonitis
01/2016
1Goiter
03/2015
1Chronic Hepatitis C
03/2015
1Nodular Goiter
03/2015

Drug/Important Bio-Agent (IBA)

3Hepatitis B e AntigensIBA
10/2020 - 01/2013
3DNA (Deoxyribonucleic Acid)IBA
10/2020 - 01/2018
2Hepatitis B Surface Antigens (HBsAg)FDA Link
01/2020 - 01/2013
1Taurocholic Acid (Sodium Taurocholate)IBA
01/2022
1Messenger RNA (mRNA)IBA
01/2022
1Nanog Homeobox ProteinIBA
01/2022
1sodium-bile acid cotransporterIBA
01/2022
1phosphoserine aminotransferase (phosphoserine transaminase)IBA
01/2021
1Biological ProductsIBA
01/2021
1Long Noncoding RNAIBA
01/2021
1Pharmaceutical PreparationsIBA
11/2020
1nasIBA
01/2020
1AntigensIBA
01/2020
1Oxidoreductases (Dehydrogenase)IBA
10/2018
1Aldo-Keto Reductase Family 1 member B10IBA
10/2018
1TelbivudineFDA Link
01/2018
1Vitamin DFDA LinkGeneric
01/2016
1VitaminsIBA
01/2016
125-hydroxyvitamin DIBA
01/2016
1D-LL-37IBA
01/2016
1AutoantibodiesIBA
03/2015
1hepatitis B hyperimmune globulinIBA
01/2013
1Hepatitis B Vaccines (Hepatitis B Vaccine)IBA
01/2013
1Immunoglobulins (Immunoglobulin)IBA
01/2013

Therapy/Procedure

1Therapeutics
10/2020